This comprehensive Klotho FAQ provides biomedical researchers and laboratory personnel with detailed technical information regarding the biological mechanisms, analytical standards, and reconstitution protocols of Klotho research peptides. Designed exclusively for in vitro assay development and preclinical investigation, this guide covers critical parameters necessary for maintaining peptide stability and reproducibility across experimental workflows. Discover how PX1 Research ensures the highest standards of analytical purity and quality control for advanced laboratory research.
This comprehensive Klotho FAQ provides biomedical researchers and laboratory personnel with detailed technical information regarding the biological mechanisms, analytical standards, and reconstitution protocols of Klotho research peptides. Designed exclusively for in vitro assay development and preclinical investigation, this guide covers critical parameters necessary for maintaining peptide stability and reproducibility across experimental workflows. Discover how PX1 Research ensures the highest standards of analytical purity and quality control for advanced laboratory research.
Klotho is a membrane-bound and soluble protein heavily investigated in cellular senescence, renal function, metabolic regulation, and neurobiology. Originally identified in rodent knockout models exhibiting accelerated aging phenotypes, Klotho functions as an obligate co-receptor for fibroblast growth factor 23 (FGF23) and acts independently as an endocrine humoral factor. Researchers evaluating the Klotho peptide focus primarily on its involvement in modulating oxidative stress response, phosphate homeostasis, and insulin signaling pathways.
In biomedical literature, Klotho expression decreases with age in various rodent tissues, making recombinant and synthetic Klotho fragments critical tools for investigating anti-senescence dynamics. Laboratories utilizing these compounds investigate how exogenous supplementation alters signaling cascades in cell culture and animal models. All materials provided by PX1 Research are synthesized strictly for laboratory research use only and are not intended for human or veterinary administration.
The native human Klotho gene encodes a single-pass transmembrane protein comprising an extracellular domain with two internal repeats, designated as KL1 and KL2. Enzymatic cleavage by membrane-anchored metalloproteinases (such as ADAM10 and ADAM17) sheds the extracellular domain into circulation, generating the soluble form of Klotho. In laboratory settings, researchers work with specific recombinant fragments or synthesized functional domains depending on the targeted assay system.
Alpha-Klotho (α-Klotho) is the primary isoform implicated in systemic mineral homeostasis and FGF23 binding. Beta-Klotho (β-Klotho), a homologous family member, predominantly interacts with FGF21 and FGF19 to regulate lipid and glucose metabolism. Accurately characterizing the molecular weight, sequence fidelity, and folding state of these fragments via high-performance liquid chromatography (HPLC) and mass spectrometry (MS) is essential prior to initiating in vitro receptor-binding assays.
Preclinical studies suggest that transmembrane Klotho forms a binary complex with fibroblast growth factor receptor 1c (FGFR1c), dramatically increasing its affinity for FGF23. This interaction triggers downstream phosphorylation cascades, including the Ras/MAPK and PI3K/Akt pathways, which regulate renal ion transport and vitamin D biosynthesis. In vitro data indicate that soluble Klotho acts as an enzymatic glycosidase or non-enzymatic ligand that modulates ion channels such as TRPV5 and renal potassium channels.
Furthermore, soluble Klotho fragments have been shown in cell culture models to inhibit Wnt/β-catenin signaling and suppress transforming growth factor-beta 1 (TGF-β1) pathways, thereby reducing fibrotic gene expression. Understanding these multi-faceted signaling networks requires high-purity peptides that do not introduce batch-to-batch variability or non-specific cellular cytotoxicity during long-term incubation assays.
When designing preclinical assays targeting cellular lifespan, mitochondrial output, and senolytic responses, investigators often compare Klotho against other established target peptides. While Klotho operates primarily through transmembrane receptor modification and humoral signaling, compounds such as Epitalon function via telomerase activation pathways in rodent models, providing a distinct angle on cellular longevity research.
Similarly, researchers examining senolytic mechanisms frequently contrast Klotho's anti-fibrotic action with FOXO4-DRI, a targeted peptide designed to disrupt FOXO4-p53 interaction and selectively induce apoptosis in senescent cells. For studies focused on mitochondrial bioenergetics and ROS scavenging, SS-31 offers cardiolipin-targeted mitochondrial membrane stabilization. Evaluating these diverse mechanisms across our broader catalog of longevity research compounds allows laboratories to cross-validate key markers of cellular stress and decay.
Experimental reproducibility relies entirely on chemical purity and exact sequence confirmation. PX1 Research subjects every synthesis lot of Klotho to rigorous analytical validation. Reverse-phase HPLC establishes chemical purity thresholds—guaranteeing ≥98% purity—by resolving structural isomers, truncated sequences, and protecting group adducts that could obscure biological results.
Electrospray ionization mass spectrometry (ESI-MS) or MALDI-TOF analysis is simultaneously conducted to verify the precise monoisotopic mass of the synthesized construct. Every order is accompanied by a lot-specific Certificate of Analysis (COA) issued by an independent ISO 17025 accredited laboratory, giving research facilities complete transparent verification of product identity and purity before starting bench experiments.
Bacterial endotoxins (lipopolysaccharides, or LPS) present a severe confounding factor in cell culture and animal models. Presence of trace endotoxin can activate Toll-like receptor 4 (TLR4), triggering inflammatory cytokine release that masks or skews the true physiological impact of the research peptide. PX1 Research enforces strict limits on endotoxin levels, testing all batches using chromogenic Limulus Amebocyte Lysate (LAL) assays.
By enforcing endotoxin thresholds below 0.01 EU/mg, PX1 Research ensures that observed experimental outcomes—such as changes in macrophage polarization or renal tubule cell viability—are strictly attributable to the recombinant peptide itself. Researchers can review detailed endotoxin assay validation criteria in our centralized technical database.
Lyophilized research peptides must be reconstituted using standardized laboratory practices to avoid denaturing secondary structures or causing premature aggregation. For most in vitro applications, sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile phosphate-buffered saline (PBS, pH 7.4) is selected depending on the final experimental protocol and assay sensitivity.
When handling Klotho fragments, gently add the solvent along the internal wall of the glass vial rather than jetting liquid directly onto the lyophilized cake. Allow the cake to dissolve naturally or assist dissolution using gentle manual rotation. Avoid high-shear vortexing or aggressive agitation, as structural shearing or foam generation can degrade the peptide backbone. For step-by-step preparation guidelines, consult our detailed reconstitution protocols.
Lyophilized Klotho peptides demonstrate optimal stability when stored in a desiccated environment at -20°C or -80°C prior to reconstitution. Under these ultra-low temperature conditions, the peptide matrix remains stable against hydrolytic degradation and oxidation for extended storage periods.
Once reconstituted into aqueous solution, the peptide should be split into single-use aliquots using low-protein-binding microcentrifuge tubes. Store these working aliquots at -80°C for long-term storage or 4°C for short-term use (up to 7 days depending on buffer composition). Subjecting reconstituted peptides to repeated freeze-thaw cycles leads to ice crystal formation, physical shearing, and precipitation, which significantly diminishes bioactivity in functional assays.
In vitro models utilizing primary human renal proximal tubule epithelial cells (RPTECs) or vascular endothelial cell lines regularly deploy Klotho to measure changes in intracellular reactive oxygen species (ROS), senescence-associated beta-galactosidase (SA-β-gal) expression, and nitric oxide synthase (eNOS) activation. Preclinical studies suggest that Klotho exposure preserves endothelial cell junctions during induced inflammatory challenge.
In rodent models, research protocols evaluate Klotho administration via peripheral or intracerebroventricular infusion to examine cognitive performance metrics, synaptic plasticity markers (such as GluN2B expression), and renal fibrosis parameters. Integrating additional metabolic probes like MOTS-c alongside Klotho in murine models provides insights into systemic energy expenditure and AMPK activation networks.
PX1 Research operates dedicated, USA-based synthesis and fulfillment operations located across facilities in California and Arizona. This dual-hub infrastructure enables rapid order dispatch, including same-day shipping for orders processed Monday through Friday prior to cutoff times. Fast domestic transit mitigates thermal exposure risks during transit for temperature-sensitive reagents.
Principal investigators, procurement officers, and contract research organizations (CROs) requiring specialized lot sizes, custom synthesis parameters, or recurring delivery schedules can leverage our streamlined institutional wholesale portal. Our technical support staff is available to provide detailed COA documentation, custom concentration options, and bulk packaging tailored to institutional standards. Access full data resources via the PX1 Research Library.
What is Klotho and what is its primary role in research?
Klotho is a membrane-bound and secreted protein studied extensively in preclinical research for its roles in modulating oxidative stress, regulating phosphate/vitamin D homeostasis, and interacting with FGF receptors. It is supplied purely as a research peptide for in vitro and animal laboratory models.
How does PX1 Research verify Klotho peptide purity?
Every lot of Klotho synthesized for PX1 Research undergoes rigorous testing using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify ≥98% purity, alongside Electrospray Ionization Mass Spectrometry (ESI-MS) for exact molecular weight confirmation. Tests are performed by independent ISO 17025 accredited facilities.
What endotoxin levels are guaranteed for Klotho research peptides?
PX1 Research subjects every batch to chromogenic Limulus Amebocyte Lysate (LAL) testing to ensure endotoxin levels remain strictly below 0.01 EU/mg, preventing background inflammatory activation in sensitive cell culture and animal models.
What solvent should be used to reconstitute Klotho for in vitro assays?
Reconstitution depends on downstream assay requirements. Standard solvents include sterile Bacteriostatic Water or sterile PBS (pH 7.4). Solvents should be added gently along the vial wall without aggressive vortexing to prevent peptide denaturing.
How should reconstituted Klotho be stored to maintain biological activity?
Reconstituted Klotho should be divided into single-use micro-aliquots in low-binding tubes and stored at -80°C. Avoid repeated freeze-thaw cycles, which cause structural degradation and protein aggregation.
What is the difference between Alpha-Klotho and Beta-Klotho in experimental designs?
Alpha-Klotho acts predominantly as a co-receptor for FGF23 and modulates renal/systemic mineral homeostasis and cellular senescence pathways. Beta-Klotho primarily interacts with FGF19 and FGF21 to regulate metabolic and lipid pathways.
How does Klotho compare to Epitalon or FOXO4-DRI in cellular aging research?
Klotho modulates transmembrane signaling, FGF binding, and Wnt/TGF-β inhibition. Epitalon focuses primarily on telomerase expression, while FOXO4-DRI functions as a senolytic disruptor of p53-FOXO4 binding. They represent distinct mechanistic arms in longevity research.
Are PX1 Research peptides synthesized in the USA?
Yes. All PX1 Research compounds are synthesized in state-of-the-art, GMP-compliant facilities located in the USA and shipped directly from our primary distribution hubs in California and Arizona.
Can Klotho peptides be provided with custom sequence lengths or modifications?
Yes, through our institutional research and wholesale division, PX1 Research provides custom peptide synthesis, specific fragment lengths (such as isolated KL1 or KL2 domains), and specific purity grades upon request.
What documentation accompanies a shipment of Klotho from PX1 Research?
Each shipment includes a lot-specific Certificate of Analysis (COA) detailing HPLC chromatograms, mass spectrometry profiles, endotoxin test results, and batch purity percentages.
Can Klotho be used for human health or clinical trials?
No. Klotho peptides supplied by PX1 Research are strictly intended for laboratory research use only by qualified scientific personnel in vitro or in preclinical animal models. They are never intended for human or clinical application.
How quickly are Klotho research shipments dispatched?
Orders placed Monday through Friday before cutoff times are dispatched same-day from our California or Arizona facilities using thermal-protective packaging to ensure compound integrity upon arrival.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.